Complexa, Inc.: Clinical Trials

4 trials sponsored by Complexa, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated, 1 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Terminated 3, Completed 1

Follow Complexa, Inc.: new trials by email

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Oral CXA-10 in Pulmonary Arterial Hypertension
CXA-10 - Pulmonary Arterial Hypertension
Phase 2TerminatedGladwin, Mark, MD12019-10-312022-01-12
CXA-10 Study in Subjects With Pulmonary Arterial Hypertension
CXA-10 - PAH
Phase 2TerminatedComplexa, Inc.332019-08-092020-08-26
PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)
75mg CXA-10, 150mg CXA-10, Placebo - PAH
Phase 2TerminatedComplexa, Inc.692018-08-012020-08-10
FIRSTx - A Study of Oral CXA-10 in Primary Focal Segmental Glomerulosclerosis (FSGS)
CXA-10 - Primary Focal Segmental Glomerulosclerosis
Phase 2CompletedComplexa, Inc.332018-04-152020-08-03

Conditions studied

Pulmonary Arterial Hypertension (3)  ·  Cardiovascular Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Familial Primary Pulmonary Hypertension (2)  ·  Hypertension (2)  ·  Hypertension, Pulmonary (2)  ·  Lung Diseases (2)  ·  Vascular Diseases (2)  ·  Kidney Diseases (1)  ·  Nephrotic Syndrome (1)  ·  Proteinuria (1)

Interventions

CXA-10 (4)

Countries

United States (4)  ·  United Kingdom (2)

Top investigators

Theo Danoff, MD (2)  ·  Marc Simon, MD (1)  ·  Theodore Danoff, MD (1)

NIH funding

P01HL103455 (1)